The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the India ayurvedic products market to exhibit a CAGR of around 15% during 2021-2026.
The changing consumer inclination from chemical-based drugs towards natural and organic medicines with numerous health benefits is driving the India ayurvedic products market.
Sudden outbreak of the COVID-19 pandemic has catalyzed the demand for numerous ayurvedic products with naturally-sourced ingredients for boosting immunity and lowering the risk of coronavirus infection.
Based on the product type, the India ayurvedic products market has been segregated into healthcare products and personal care products, where personal care products currently represent the largest segment.
Based on the organized/unorganized, the India ayurvedic products market can be categorized into organized and unorganized. Currently, organized sector exhibits a clear dominance in the market.
On a regional level, the market has been classified into North India, East India, West and Central India, and South India, where North India currently dominates the market.
Some of the major players in the India ayurvedic products market include Dabur India Ltd., Patanjali Ayurved Limited, The Himalaya Drug Company, Vicco Laboratories, Charak Pharma Pvt. Ltd., Hamdard Laboratories, Forest Essentials, Emami Ltd., Shree Baidyanath Ayurved Bhawan Pvt. Ltd., Kerala Ayurveda Ltd., Amrutanjan Healthcare Limited, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at